ARWR - ARROWHEAD PHARMACEUTICALS, INC.

QQQ $ 439.55 $ -0.26 (-0.06 %)

DIA $ 390.50 $ 1.74 (0.45 %)

SPY $ 517.10 $ 0.05 (0.01 %)

TLT $ 90.18 $ -0.55 (-0.61 %)

GLD $ 213.58 $ -0.63 (-0.29 %)

Previous Close

$ 25.22

Open

$ 24.79

Bid

$ 0.00 x 0

Ask

$ 25.23 x 100

Day's Range

$ 24.33 - $ 25.24

52 Week Range

$ 20.67 - $ 41.28

Volume

906,027

Average Volume

Market Cap

2.71B

Beta (5Y Monthly)

$ 1.08

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	02-06-2024	12-31-2023	10-Q
2	11-29-2023	09-30-2023	10-K
3	08-07-2023	06-30-2023	10-Q
4	05-02-2023	03-31-2023	10-Q
5	02-06-2023	12-31-2022	10-Q
6	11-28-2022	09-30-2022	10-K
7	08-04-2022	06-30-2022	10-Q
8	05-10-2022	03-31-2022	10-Q
9	02-02-2022	12-31-2021	10-Q
10	11-22-2021	09-30-2021	10-K
11	08-05-2021	06-30-2021	10-Q
12	05-04-2021	03-31-2021	10-Q
13	02-04-2021	12-31-2020	10-Q
14	11-23-2020	09-30-2020	10-K
15	08-05-2020	06-30-2020	10-Q
16	05-07-2020	03-31-2020	10-Q
17	02-05-2020	12-31-2019	10-Q
18	11-25-2019	09-30-2019	10-K
19	08-05-2019	06-30-2019	10-Q
20	05-08-2019	03-31-2019	10-Q
21	02-07-2019	12-31-2018	10-Q
22	12-11-2018	09-30-2018	10-K
23	08-07-2018	06-30-2018	10-Q
24	05-08-2018	03-31-2018	10-Q
25	02-09-2018	12-31-2017	10-Q
26	12-12-2017	09-30-2017	10-K
27	08-03-2017	06-30-2017	10-Q
28	05-03-2017	03-31-2017	10-Q
29	02-06-2017	12-31-2016	10-Q
30	12-14-2016	09-30-2016	10-K
31	08-09-2016	06-30-2016	10-Q
32	05-10-2016	03-31-2016	10-Q
33	02-09-2016	12-31-2015	10-Q
34	12-14-2015	09-30-2015	10-K
35	08-04-2015	06-30-2015	10-Q
36	05-11-2015	03-31-2015	10-Q
37	02-09-2015	12-31-2014	10-Q
38	11-25-2014	09-30-2014	10-K
39	08-12-2014	06-30-2014	10-Q
40	05-06-2014	03-31-2014	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

amgen-reports-better-than-expected-q1-results-50m-milestone-payment

Amgen Reports Better-Than-Expected Q1 Resu...
05/02/2024 21:44:40

Amgen reported quarterly earnings of $3.96 per share which beat the analyst consensus estimate of $3.87 by 2.33%. The company s...

Arrowhead Pharmaceuticals Earns $50M Miles...
05/02/2024 20:39:45

Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) today announced a $50 million milestone payment was received from Royalty Pharma ...

Arrowhead Pharmaceuticals Has Dosed The Fi...
04/24/2024 11:32:50

Reported Sunday, Arrowhead Pharmaceuticals...
04/08/2024 06:54:27

- Plozasiran reduced triglycerides and APOC3 up to a mean maximum of 86% and 90% respectively in patients with severe hypertr...

NetApp, Zoom Video And 2 Other Stocks Insi...
04/04/2024 11:23:01

The Nasdaq 100 closed higher by around 0.2% on Wednesday. Investors, meanwhile, focused on some notable insider trades.

Arrowhead Pharmaceuticals Initiates Expand...
03/25/2024 12:05:29

eqt-genie-energy-and-other-big-stocks-moving-lower-on-monday

EQT, Genie Energy And Other Big Stocks Mov...
03/11/2024 14:37:32

U.S. stocks were lower, with the Dow Jones index falling more than 150 points on Monday.

Arrowhead Pharmaceuticals Says It Initiate...
03/08/2024 12:34:13

cooper-companies-reports-upbeat-results-joins-dell-netapp-tidewater-and-other-big-stocks-moving-higher-on-friday

Cooper Companies Reports Upbeat Results, J...
03/01/2024 16:18:21

U.S. stocks were higher, with the Nasdaq Composite gaining around 0.5% on Friday.

Blog Chatter Suggests "People Following Th...
02/28/2024 18:20:49

Watching Arrowhead Pharmaceuticals; Trader...
02/28/2024 18:18:53

HC Wainwright & Co. Reiterates Buy on Arro...
02/08/2024 20:27:36

HC Wainwright & Co. analyst Patrick Trucchio reiterates Arrowhead Pharma (NASDAQ:ARWR) with a Buy and maintains $90 pric...

Citigroup Maintains Neutral on Arrowhead P...
02/07/2024 19:07:28

Citigroup analyst Shawn Egan maintains Arrowhead Pharma (NASDAQ:ARWR) with a Neutral and raises the price target from $33 to...

Cracking The Code: Understanding Analyst R...
02/07/2024 17:01:02

RBC Capital Reiterates Outperform on Arrow...
02/07/2024 16:55:02

RBC Capital analyst Luca Issi reiterates Arrowhead Pharma (NASDAQ:ARWR) with a Outperform and maintains $50 price target.

12-health-care-stocks-moving-in-tuesdays-after-market-session

12 Health Care Stocks Moving In Tuesday's ...
02/06/2024 21:31:18

Recap: Arrowhead Pharma Q1 Earnings
02/06/2024 21:10:42

Arrowhead Pharma Q1 EPS $(1.24) Misses $(0...
02/06/2024 21:07:20

Arrowhead Pharma (NASDAQ:ARWR) reported quarterly losses of $(1.24) per share which missed the analyst consensus estimate of $(...

Earnings Scheduled For February 6, 2024
02/06/2024 10:42:06

Companies Reporting Before The Bell • BP (NYSE:BP) is projected to report quarterly earnings at $1.05 per share on revenue of ...

RBC Capital Reiterates Outperform on Arrow...
01/16/2024 14:17:10

RBC Capital analyst Luca Issi reiterates Arrowhead Pharma (NASDAQ:ARWR) with a Outperform and maintains $50 price target.